While PH Awareness Month is a great opportunity to connect and educate, rare disease advocacy is columnist Jen Cueva's passion all year.
Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...
Abnormalities in levels of microRNAs, affecting protein production, may tie to CTEPH development and progression; possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback